Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17500
Corporate User License Price USD 750
Corporate User License Price INR 52500
Site License Price USD 500
Site License Price INR 35000
Request a Quote

Report Title

Innovus Pharmaceuticals Inc (INNV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Innovus Pharmaceuticals Inc (INNV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Innovus Pharmaceuticals Inc (INNV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Innovus Pharmaceuticals Inc (INNV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Innovus Pharmaceuticals Inc (Innovus Pharmaceuticals) is a pharmaceutical company that commercializes, licenses and develops over the counter and consumer healthcare products. The company's products include non-drowsy allergy relief tablets, male fertility dietary supplements, blood sugar support supplement, weight loss supplement, lean gren bean coffee extract supplement, and others. Innovus Pharmaceuticals' products are used in the areas of men's and women's health, vitality, sexual and reproductive health, pain, vision and respiratory disease. The company caters its products to urologists, primary care physicians, gynecologists, therapists and directly to consumers through on-line channels, retailers and wholesalers. Innovus Pharmaceuticals is headquartered in San Diego, California, the US.

Innovus Pharmaceuticals Inc (INNV)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 7

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11

Innovus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 12

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 17

Asset Purchase 17

Innovus Pharma Acquires Assets of Beyond Human for USD0.6 Million 17

Innovus Pharma Acquires Vesele from Trophikos 18

Innovus Pharma Amends Acquisition of Rights to Circumserum from Centric Research for up to USD7.5 Million 19

Innovus Pharma To Acquire Prescription Product Portfolio From Prospector Capital Partners II 20

Venture Financing 22

Innovus Pharma Raises USD 0.33 Million In Venture Financing 22

Innovus Pharma To Raise USD 1.1 Million In Venture Financing 23

Partnerships 24

Innovus Pharma Enters into Distribution Agreement with Laboratorios Q Pharma 24

Innovus Pharma Enters into Co-Marketing Agreement with DanaLife for Zestra 25

Innovus Pharma Enters Into Co-Promotion Agreement With Consortia Health For EjectDelay 26

Licensing Agreements 27

Innovus Pharma Enters into License and Distribution Agreement with Lavasta Pharma 27

Corporacion Pharma Solutions Peru Enters into Licensing Agreement with Innovus Pharma 28

Innovus Pharma Plans to Enter into Licensing Agreement with University of Iowa Research Foundation 29

Luminarie Enters into Licensing Agreement with Innovus Pharma 30

Innovus Pharma Expands Licensing Agreement with Densmore for Zestra 31

Innovus Pharma Enters into Licensing Agreement with NTC 32

Innovus Pharma Enters into Licensing Agreement with J&H Co. for Zestra 33

Elis Pharma Enters into Licensing Agreement with Innovus Pharma for Zestra 34

Innovus Pharma Enters into Licensing Agreement with Seipel 35

Innovus Pharma Enters into Licensing Agreement with BroadMed for EjectDelay 36

Bio Task Enters into Licensing Agreement with Innovus Pharma 37

Khandelwal Labs Enters into Licensing Agreement with Innovus Pharma 38

Elis Pharma Enters into Licensing Agreement with Innovus Pharma 39

BroadMed Enters into Licensing Agreement with Innovus Pharma for Sensum+ 40

Innovus Pharma Enters into Licensing Agreement with Tabuk Pharma 41

Innovus Pharma Enters into Licensing Agreement with Sothema Labs 42

Innovus Pharma Enters into Licensing Agreement with Tramorgan for Sensum+ 43

Orimed Pharma Expands Licensing Agreement with Innovus Pharma 44

Innovus Pharma Enters Into Licensing Agreement With Ovation Pharma For EjectDelay 45

Innovus Pharma Enters Into License And Distribution Agreement With Ovation Pharma For Circumserum 46

Acerus Pharma Enters into Licensing and Distribution Agreement with Innovus Pharma 47

Equity Offering 48

Innovus Pharma Raises Funds through Private Placement 48

Innovus Pharma Prices Public Offering of Shares for USD3.9 Million 49

Innovus Pharma Files Registration Statement for Public Offering of Shares and Warrants for up to USD5 Million 50

Innovus Pharma to Raise Funds in Public Offering of Shares 51

Innovus Pharma to Raise USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 52

Innovus Pharma Completes Private Placement Of Shares For USD 0.13 Million 53

Innovus Pharma Completes Private Placement Of Shares For USD 0.45 Million 54

Innovus Pharma Completes Private Placement Of Shares For USD 4.5 Million 55

Debt Offering 56

Innovus Pharma Raises USD0.8 Million in Third and Final Tranche of Private Placement of 10% Notes Due 2017 56

Innovus Pharma Raises Additional USD0.75 Million in Private Placement of 10% Note Due 2017 57

Innovus Pharma Raises USD1.5 Million in Private Placement of 10% Note Due 2017 58

Innovus Pharmaceuticals Raises USD0.024 Million in Debt Offering of 10% Non-Convertible Debentures 59

Innovus Pharma Raises USD0.5 Million in Private Placement of 5% Notes Due 2016 60

Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 61

Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 62

Innovus Pharma Raises USD0.1 Million in Private Placement of Notes 63

Innovus Pharma Raises USD0.1 Million in Private Placement of 8% Debentures 64

Innovus Pharma Amends Private Placement of 8% Debenture Due 2016 65

Innovus Pharma Raises USD0.3 Million in Private Placement of 10% Debentures due 2015 66

Innovus Pharma Raises USD0.4 Million in Private Placement of 8% Debentures due 2014 67

Innovus Pharma Raises USD0.1 Million in Private Pacement of Convertible Debt 68

Innovus Pharma Raises USD0.2 Million in Private Placement of 8% Debentures 69

Asset Transactions 70

Apricus Biosciences Acquires Remaining 50% Stake Of Rights To PrevOnco From Innovus Pharma 70

Acquisition 71

Innovus Pharma Acquires Novalere 71

Innovus Pharma Acquires Semprae Labs 72

Innovus Pharmaceuticals Inc-Key Competitors 73

Innovus Pharmaceuticals Inc-Key Employees 74

Innovus Pharmaceuticals Inc-Locations And Subsidiaries 75

Head Office 75

Other Locations & Subsidiaries 75

Recent Developments 76

Strategy And Business Planning 76

Oct 16, 2018: Innovus Pharma to expand its Amazon store to Japan 76

Jun 21, 2018: Innovus Pharma Receives Approval from Amazon to Expand its Amazon Stores to Europe Covering the United Kingdom, France, Germany, Spain and Italy 77

Financial Announcements 78

Jul 17, 2018: Innovus Pharmaceuticals Reports Preliminary Q2 2018 Sales Revenue of USD 6.6 million to USD 6.8 million 78

May 14, 2018: Innovus Pharmaceuticals announces quarterly revenue for Q1 2018 79

Apr 02, 2018: Innovus Pharmaceuticals Reports Record Annual Revenue for Fiscal 2017 of USD 8.8 Million, Preliminary Q1 2018 Revenue of USD 4.3 Million to USD 4.4 Million 80

Nov 14, 2017: Innovus Pharmaceuticals Reports Nine Month Net Revenue of USD 6.4 million and Net Loss Decrease of 51.6% Compared to the Same Period in 2016 81

Aug 14, 2017: Innovus Pharmaceuticals Reports a Quarterly Net Revenue Increase of 99.2% and Net Loss Decrease of 74.1% Compared to the Same Period in 2016 82

May 12, 2017: Innovus Pharmaceuticals Reports Quarterly Revenue for the First Quarter 2017 of USD 2.2 Million 83

Mar 06, 2017: Innovus Pharmaceuticals Reports Record Annual Revenues for the Full Year 2016 of USD 4.8 Million 84

Corporate Communications 85

Apr 23, 2018: Innovus Pharma Expands its Senior Management with the Addition of Ryan Selhorn, CPA, as its Vice President, Chief Financial Officer 85

Legal and Regulatory 86

Dec 04, 2017: Innovus Pharma Files Application for the Commercialization of ProstaGorx for Benign Prostatic Hyperplasia ("BPH") as a Natural Health Product in Canada 86

Oct 18, 2017: Innovus Pharma Receives Approval from Health Canada for Vesele as a Natural Health Product 87

Product News 88

Nov 14, 2017: Innovus Pharma Launches FlutiCare OTC Nasal Spray Allergy Relief in the U.S. 88

Sep 19, 2017: Innovus Pharma Announces the Launch of Zestra in France, Belgium and Monaco by Its Partner, Densmore 89

Jun 01, 2017: Innovus Pharma Announces Positive Pre-Clinical Synergistic Effects of Vesele in Combination with Sildenafil on Nitric Oxide Production 90

May 24, 2017: Innovus Pharma Launches AllerVarx, a Clinically Proven Supplement for the Relief of Allergy Symptoms, in the United States 91

May 01, 2017: Innovus Pharma Launches ProstaGorx Product for Prostate Health Through its Beyond Human Sales and Marketing Platform in the United States 92

Apr 13, 2018: Innovus Pharma Announces Its Direct Launch of Apeaz, a Cream for Arthritis Pain Relief, in Canada 93

Other Significant Developments 94

Jan 18, 2018: Innovus Pharma Announces Official Launch of its Amazon, Walmart, eBay and Wish On-Line Stores with a Combined 116 Product SKUs 94

Aug 09, 2017: Innovus Pharma Orders its First Commercial Batch of 220,000 Units of FlutiCare 96

Apr 05, 2017: Innovus Pharma Announces Receipt of Notification to Commercialize Zestra Glide in the European Union 97

Mar 02, 2017: Innovus Pharma Announces Receipt of Notification to Commercialize Zestra in the European Union 98

Appendix 99

Methodology 99

About GlobalData 99

Contact Us 99

Disclaimer 99

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 9

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11

Innovus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 12

List of Tables

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Innovus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 11

Innovus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 12

Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

Innovus Pharma Acquires Assets of Beyond Human for USD0.6 Million 17

Innovus Pharma Acquires Vesele from Trophikos 18

Innovus Pharma Amends Acquisition of Rights to Circumserum from Centric Research for up to USD7.5 Million 19

Innovus Pharma To Acquire Prescription Product Portfolio From Prospector Capital Partners II 20

Innovus Pharma Raises USD 0.33 Million In Venture Financing 22

Innovus Pharma To Raise USD 1.1 Million In Venture Financing 23

Innovus Pharma Enters into Distribution Agreement with Laboratorios Q Pharma 24

Innovus Pharma Enters into Co-Marketing Agreement with DanaLife for Zestra 25

Innovus Pharma Enters Into Co-Promotion Agreement With Consortia Health For EjectDelay 26

Innovus Pharma Enters into License and Distribution Agreement with Lavasta Pharma 27

Corporacion Pharma Solutions Peru Enters into Licensing Agreement with Innovus Pharma 28

Innovus Pharma Plans to Enter into Licensing Agreement with University of Iowa Research Foundation 29

Luminarie Enters into Licensing Agreement with Innovus Pharma 30

Innovus Pharma Expands Licensing Agreement with Densmore for Zestra 31

Innovus Pharma Enters into Licensing Agreement with NTC 32

Innovus Pharma Enters into Licensing Agreement with J&H Co. for Zestra 33

Elis Pharma Enters into Licensing Agreement with Innovus Pharma for Zestra 34

Innovus Pharma Enters into Licensing Agreement with Seipel 35

Innovus Pharma Enters into Licensing Agreement with BroadMed for EjectDelay 36

Bio Task Enters into Licensing Agreement with Innovus Pharma 37

Khandelwal Labs Enters into Licensing Agreement with Innovus Pharma 38

Elis Pharma Enters into Licensing Agreement with Innovus Pharma 39

BroadMed Enters into Licensing Agreement with Innovus Pharma for Sensum+ 40

Innovus Pharma Enters into Licensing Agreement with Tabuk Pharma 41

Innovus Pharma Enters into Licensing Agreement with Sothema Labs 42

Innovus Pharma Enters into Licensing Agreement with Tramorgan for Sensum+ 43

Orimed Pharma Expands Licensing Agreement with Innovus Pharma 44

Innovus Pharma Enters Into Licensing Agreement With Ovation Pharma For EjectDelay 45

Innovus Pharma Enters Into License And Distribution Agreement With Ovation Pharma For Circumserum 46

Acerus Pharma Enters into Licensing and Distribution Agreement with Innovus Pharma 47

Innovus Pharma Raises Funds through Private Placement 48

Innovus Pharma Prices Public Offering of Shares for USD3.9 Million 49

Innovus Pharma Files Registration Statement for Public Offering of Shares and Warrants for up to USD5 Million 50

Innovus Pharma to Raise Funds in Public Offering of Shares 51

Innovus Pharma to Raise USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 52

Innovus Pharma Completes Private Placement Of Shares For USD 0.13 Million 53

Innovus Pharma Completes Private Placement Of Shares For USD 0.45 Million 54

Innovus Pharma Completes Private Placement Of Shares For USD 4.5 Million 55

Innovus Pharma Raises USD0.8 Million in Third and Final Tranche of Private Placement of 10% Notes Due 2017 56

Innovus Pharma Raises Additional USD0.75 Million in Private Placement of 10% Note Due 2017 57

Innovus Pharma Raises USD1.5 Million in Private Placement of 10% Note Due 2017 58

Innovus Pharmaceuticals Raises USD0.024 Million in Debt Offering of 10% Non-Convertible Debentures 59

Innovus Pharma Raises USD0.5 Million in Private Placement of 5% Notes Due 2016 60

Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 61

Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 62

Innovus Pharma Raises USD0.1 Million in Private Placement of Notes 63

Innovus Pharma Raises USD0.1 Million in Private Placement of 8% Debentures 64

Innovus Pharma Amends Private Placement of 8% Debenture Due 2016 65

Innovus Pharma Raises USD0.3 Million in Private Placement of 10% Debentures due 2015 66

Innovus Pharma Raises USD0.4 Million in Private Placement of 8% Debentures due 2014 67

Innovus Pharma Raises USD0.1 Million in Private Pacement of Convertible Debt 68

Innovus Pharma Raises USD0.2 Million in Private Placement of 8% Debentures 69

Apricus Biosciences Acquires Remaining 50% Stake Of Rights To PrevOnco From Innovus Pharma 70

Innovus Pharma Acquires Novalere 71

Innovus Pharma Acquires Semprae Labs 72

Innovus Pharmaceuticals Inc, Key Competitors 73

Innovus Pharmaceuticals Inc, Key Employees 74

Innovus Pharmaceuticals Inc, Subsidiaries 75

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Innovus Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person